Novartis Recalls Theraflu MAX-D Powder Packets Due to Foreign Substances
Novartis Consumer Health is recalling Theraflu MAX-D and NeoCitran powder packets because they may contain foreign substances.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Novartis Consumer Health is recalling specific lots of Theraflu MAX-D Severe Cold & Flu powder packets and NeoCitran Extra Strength Total 7 Symptom Relief Plus Mucous Relief powder packets. The recall is being conducted because the products may contain foreign substances.
The affected products include Theraflu MAX-D Severe Cold & Flu (acetaminophen 1000 mg, dextromethorphan HBr 30 mg, guaifenesin 400 mg, pseudoephedrine HCl 60 mg) powder packets in Natural Citrus flavor, and NeoCitran Extra Strength Total 7 Symptom Relief Plus Mucous Relief powder packets in Soothing Lemon flavor. The recall covers 868,104 cartons distributed nationwide in the United States, as well as in Mexico, Russia, Korea, Panama, China, and Canada.
Consumers should check their cartons for the specific lot numbers and expiration dates listed in the recall notice. If the product matches the recalled lots, consumers should stop using it and contact Novartis Consumer Health for further instructions.
The recalled product
- Product
- Theraflu MAX-D Severe Cold & Flu (acetaminophen 1000 mg, dextromethorphan HBr 30 mg, guaifenesin 400 mg, pseudoephedrine HCl 60 mg) powder packets, Natural Citrus flavor, 6-count packets per carton, Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 07054-0622, NDC
- Manufacturer
- Novartis Consumer Health
- Category
- Drug — Cold & Flu Medication
- Hazard
- Affected units
- 868,104
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 10089568
- Exp 5/31/2013
- 10093324
- 10094745
- 10097626
- 10097627
- Exp 7/31/2013
- 10098588
- 10098591
- Exp 9/30/2013
- 10101027
- Exp 10/31/2013
- 10102623
- Exp 11/30/2013
- 10106813
- Exp 1/31/2014
- 10115844
- Exp 6/30/2014
- 10124363
- Exp 9/30/2014.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Severe Cold & Cough Powder Packets for Foreign Substances
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01